Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck & Co.
Biotech
Biopharma M&A more than doubled in Q1 compared to a year ago
There was a record amount of money raised from public offerings and PIPEs in the first quarter of 2024.
Max Bayer
Apr 18, 2024 9:46am
Merck & Co. signs $208M deal for biotech to improve ADC safety
Apr 8, 2024 9:22am
Lonza lands new CEO—Chutes & Ladders
Apr 5, 2024 8:30am
Peter Marks says FDA ready to review novel cancer vaccines
Apr 3, 2024 2:39pm
Prometheus team returns with brand-new biotech and $400M
Mar 21, 2024 7:00am
Top 10 pharma R&D budgets in 2023
Mar 18, 2024 5:00am